Abstract
Amikacin is a first-line treatment for Aeromonas infection due to high efficacy. There are few reports of aminoglycoside-resistant Aeromonas spp. We report a soft tissue infection containing multiple pathogens, including a strain of Aeromonas hydrophila resistant to amikacin, tobramycin, and multiple cephalosporins.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adult
-
Aeromonas hydrophila / drug effects*
-
Aeromonas hydrophila / isolation & purification
-
Amikacin / pharmacology
-
Aminoglycosides / pharmacology*
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Infections / diagnosis
-
Bacterial Infections / microbiology*
-
Cephalosporins / pharmacology
-
Drug Resistance, Bacterial*
-
Fresh Water
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Soft Tissue Infections / diagnosis
-
Soft Tissue Infections / microbiology*
-
Tobramycin / pharmacology
-
Wounds and Injuries / complications*
Substances
-
Aminoglycosides
-
Anti-Bacterial Agents
-
Cephalosporins
-
Amikacin
-
Tobramycin